Guangzhou Lupeng Pharmaceutical Company Ltd.

This study tests an experimental pill called LP-168 in adults with B-cell lymphoma that has returned or not responded to standard treatments. The main goals are to find the safest dose and check if the drug shrinks tumors. About 200 participants will take the drug by mouth, and r…

This study tests a new drug called rocbrutinib against standard treatments for people with a hard-to-treat type of lymphoma (non-GCB DLBCL) that has come back or stopped responding. About 150 adults will be randomly assigned to receive either rocbrutinib alone or a standard chemo…

This phase 3 study tests a new drug called rocbrutinib against other targeted therapies (BTK inhibitors) for people with mantle cell lymphoma that has come back or stopped responding to treatment. About 394 adults who have had at least one prior therapy will be randomly assigned …

This study looks at how two common drugs (itraconazole and rifampin) change the way rocbrutinib moves through the body. It involves 28 healthy adults and does not aim to treat any disease. The goal is to gather safety and drug-level information for future research.